Loading company…
Lausanne-based Timeline sells Mitopure, a Urolithin A supplement intended to support healthy aging at the cellular level.
Established in 2007 by Patrick Aebischer and Pierre Landolt and based in Lausanne, Switzerland, Amazentis SA, which trades as Timeline, develops therapeutic products aimed at reversing mitochondrial aging to support muscle function. Its Mitopure line offers Urolithin A in vegetarian capsules, a compound that promotes mitophagy, the recycling of damaged mitochondria. In January 2024 Timeline raised CHF 56 million in Series D funding led by L'Oréal BOLD Ventures, with Nestle Health Science SA and other investors, to broaden its product lines across food, beauty and health.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in